3 months ago
NAGE
AnalystsRaghuram SelvarajuRaghuram Selvaraju's Stock Forecasts
AnalystsRaghuram Selvaraju
Analyst Ranking
Top 4%
#159 out of 4906 analysts
Average Return
+3.9%
Win Rate
38%377 out of 991
Risk vs Reward
Poor
Good
Raghuram Selvaraju's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | +713.02% | $6.91 | $56.18 | 2022-07-21 - 2023-07-20 | Buy |
Cormedix IncCRMD | +677.78% | $0.90 | $7.00 | 2018-05-23 - 2019-05-23 | Buy |
Anavex Life Sciences CorpAVXL | +547.79% | $2.49 | $16.13 | 2020-03-16 - 2021-03-16 | Buy |
Verona Pharma PLCVRNA | +497.15% | $15.44 | $92.20 | 2024-06-27 - 2025-06-13 | Buy |
Regulus Therapeutics IncRGLS | +496.32% | $1.36 | $8.11 | 2025-02-26 - 2025-06-13 | Buy |
Raghuram Selvaraju Analyst Color
Get additional color on Raghuram Selvaraju's coverage of popular stocks
4 months ago
PLX
a year ago
CING
3 years ago
OBSVF
Raghuram Selvaraju's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Brainsway LtdBWAY | 22 | Buy | $16.00 | +46.79% | Reiterates | 4 days ago |
Omeros CorpOMER | 5 | Buy | $9.00 | +164.71% | Initiates Coverage On | 6 days ago |
Axsome Therapeutics IncAXSM | 34 | Buy | $180.00 | +72.91% | Reiterates | 6 days ago |
Coya Therapeutics IncCOYA | 3 | Buy | $18.00 | +219.72% | Reiterates | 7 days ago |
Annovis Bio IncANVS | 19 | Buy | $12.00 | +327.05% | Maintains | 7 days ago |
Bridgebio Pharma IncBBIO | 23 | Buy | $56.00 | +40.77% | Maintains | 7 days ago |
Verona Pharma PLCVRNA | 22 | Buy | $90.00 | -2.39% | Maintains | 14 days ago |
Ovid Therapeutics IncOVID | 9 | Buy | $1.50 | +435.71% | Maintains | 20 days ago |
Cognition Therapeutics IncCGTX | 8 | Buy | $3.00 | +906.71% | Maintains | 20 days ago |
Sarepta Therapeutics IncSRPT | 2 | Hold | $40.00 | +10.56% | Reiterates | 25 days ago |
Fennec Pharmaceuticals IncFENC | 13 | Buy | $13.00 | +63.93% | Reiterates | a month ago |
Entrada Therapeutics IncTRDA | 14 | Buy | $20.00 | +163.50% | Reiterates | a month ago |
Assertio Holdings IncASRT | 5 | Buy | $3.50 | +453.80% | Reiterates | a month ago |
Gain Therapeutics IncGANX | 21 | Buy | $8.00 | +362.43% | Reiterates | a month ago |
Benitec Biopharma IncBNTC | 3 | Buy | $28.00 | +69.90% | Reiterates | a month ago |
Alpha Cognition IncACOG | 4 | Buy | $20.00 | +113.90% | Reiterates | a month ago |
Aquestive Therapeutics IncAQST | 26 | Buy | $10.00 | +192.40% | Reiterates | a month ago |
Aclaris Therapeutics IncACRS | 12 | Buy | $16.00 | +988.44% | Maintains | a month ago |
Urogen Pharma LtdURGN | 29 | Buy | $55.00 | +357.19% | Reiterates | a month ago |
Vanda Pharmaceuticals IncVNDA | 8 | Buy | $20.00 | +343.46% | Reiterates | a month ago |
Repligen CorpRGEN | 8 | Buy | $180.00 | +41.15% | Reiterates | a month ago |
Abeona Therapeutics IncABEO | 11 | Buy | $20.00 | +224.68% | Maintains | 2 months ago |
Balchem CorpBCPC | 16 | Buy | $180.00 | +11.43% | Maintains | 2 months ago |
Soleno Therapeutics IncSLNO | 6 | Buy | $100.00 | +26.34% | Reiterates | 2 months ago |
Polypid LtdPYPD | 9 | Buy | $11.00 | +222.58% | Reiterates | 2 months ago |
Microbot Medical IncMBOT | 8 | Buy | $9.00 | +284.62% | Reiterates | 2 months ago |
Genmab AGMAB | 46 | Buy | $37.00 | +62.14% | Reiterates | 2 months ago |
Niagen Bioscience IncNAGE | 19 | Buy | $11.00 | -19.30% | Reiterates | 2 months ago |
Rhythm Pharmaceuticals IncRYTM | 10 | Buy | $80.00 | +27.19% | Reiterates | 2 months ago |
Anavex Life Sciences CorpAVXL | 25 | Buy | $42.00 | +423.04% | Reiterates | 2 months ago |
Emergent Biosolutions IncEBS | 6 | Buy | $15.00 | +140.00% | Reiterates | 2 months ago |
Rockwell Medical IncRMTI | 23 | Buy | $3.00 | +219.15% | Maintains | 3 months ago |
Enlivex Therapeutics LtdENLV | 13 | Buy | $7.00 | +677.78% | Maintains | 3 months ago |
Longeveron IncLGVN | 10 | Buy | $10.00 | +669.23% | Reiterates | 3 months ago |
Inovio Pharmaceuticals IncINO | 6 | Hold | $3.00 | +50.00% | Reiterates | 3 months ago |
Entera Bio LtdENTX | 16 | Buy | $10.00 | +437.63% | Reiterates | 3 months ago |
Regenxbio IncRGNX | 1 | Buy | $34.00 | +266.77% | Maintains | 3 months ago |
Regulus Therapeutics IncRGLS | 19 | Buy | $10.00 | +23.30% | Reiterates | 3 months ago |
Rapt Therapeutics IncRAPT | 16 | Buy | $10.00 | +861.54% | Reiterates | 3 months ago |
Cingulate IncCING | 5 | Buy | $20.00 | +376.19% | Reiterates | 3 months ago |
Moonlake ImmunotherapeuticsMLTX | 28 | Buy | $100.00 | +126.19% | Reiterates | 4 months ago |
Rani Therapeutics Holdings IncRANI | 1 | Buy | $9.00 | +1,614.29% | Reiterates | 4 months ago |
Protalix Biotherapeutics IncPLX | 6 | Buy | $15.00 | +906.71% | Maintains | 4 months ago |
Spero Therapeutics IncSPRO | 18 | Buy | $5.00 | +76.68% | Reiterates | 5 months ago |
Bioxcel Therapeutics IncBTAI | 37 | Buy | $48.00 | +2,976.92% | Maintains | 5 months ago |
Hoth Therapeutics IncHOTH | 8 | Buy | $4.00 | +207.69% | Reiterates | 5 months ago |
Cocrystal Pharma IncCOCP | 14 | Buy | $7.00 | +354.55% | Reiterates | 5 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 15 | Buy | $11.00 | +1,406.85% | Maintains | 5 months ago |
Cervomed IncCRVO | 1 | Buy | $42.00 | +489.89% | Initiates Coverage On | 6 months ago |
Processa Pharmaceuticals IncPCSA | 8 | Buy | $6.00 | +2,216.60% | Reiterates | 6 months ago |
Biolife Solutions IncBLFS | 3 | Buy | $27.00 | +22.56% | Maintains | 7 months ago |
Cardiff Oncology IncCRDF | 13 | Buy | $13.00 | +241.21% | Maintains | 7 months ago |
Adma Biologics IncADMA | 16 | Buy | $26.00 | +24.94% | Maintains | 7 months ago |
Scilex Holding CoSCLX | 7 | Buy | $245.00 | +4,982.99% | Reiterates | 8 months ago |
Indaptus Therapeutics IncINDP | 12 | Buy | $12.00 | +3,592.31% | Reiterates | 8 months ago |
Addex Therapeutics LtdADXN | 7 | Buy | $30.00 | +257.87% | Reiterates | 8 months ago |
Fate Therapeutics IncFATE | 4 | Hold | $5.00 | +292.16% | Reiterates | 10 months ago |
Arcadia Biosciences IncRKDA | 13 | Buy | $6.00 | +21.21% | Reiterates | 10 months ago |
Equillium IncEQ | 11 | Buy | $5.00 | +1,340.92% | Reiterates | 10 months ago |
Kezar Life Sciences IncKZR | 17 | Buy | $70.00 | +1,425.05% | Reiterates | 10 months ago |
Oncternal Therapeutics IncONCT | 11 | Buy | $18.00 | +3,315.56% | Maintains | 10 months ago |
Sol Gel Technologies LtdSLGL | 17 | Buy | $60.00 | N/A | Reiterates | a year ago |
Landos Biopharma IncLABP | 2 | Hold | $20.42 | N/A | Downgrades | a year ago |
Karuna Therapeutics IncKRTX | 15 | Hold | $330.00 | N/A | Maintains | a year ago |
Taro Pharmaceutical Industries LtdTARO | 8 | Hold | $43.00 | N/A | Downgrades | a year ago |
Eton Pharmaceuticals IncETON | 9 | Buy | $10.00 | N/A | Reiterates | 2 years ago |
Paxmedica IncPXMD | 1 | Buy | $3.00 | N/A | Initiates Coverage On | 2 years ago |
Spruce Biosciences IncSPRB | 7 | Buy | $10.00 | N/A | Reiterates | 2 years ago |
Cosciens Biopharma IncCSCI | 10 | Buy | $60.00 | N/A | Maintains | 2 years ago |
Ensysce Biosciences IncENSC | 2 | Buy | $105.00 | N/A | Maintains | 2 years ago |
Anebulo Pharmaceuticals IncANEB | 2 | Buy | $6.00 | N/A | Reiterates | 2 years ago |
Galecto IncGLTO | 4 | Buy | $50.00 | N/A | Maintains | 2 years ago |
Cartesian Therapeutics IncRNAC | 5 | Buy | $5.00 | N/A | Reiterates | 2 years ago |
Galera Therapeutics IncGRTX | 6 | Hold | $0.30 | N/A | Downgrades | 2 years ago |
Provention Bio IncPRVB | 6 | Hold | $25.00 | N/A | Downgrades | 2 years ago |
Tourmaline Bio IncTRML | 3 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Timber Pharmaceuticals IncTMBRQ | 4 | Buy | $50.00 | N/A | Maintains | 3 years ago |
Obseva SaOBSVF | 6 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aptinyx IncAPTX | 2 | Buy | $1.00 | N/A | Maintains | 3 years ago |
Fresh Tracks Therapeutics IncFRTX | 2 | Buy | $4.50 | N/A | Maintains | 3 years ago |
Ayala Pharmaceuticals IncAYLA | 2 | Buy | $12.00 | N/A | Maintains | 3 years ago |
Evofem Biosciences IncEVFM | 8 | Buy | $4.00 | N/A | Maintains | 3 years ago |
Elicio Therapeutics IncELTX | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Tyra Biosciences IncTYRA | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 3 years ago |
Neubase Therapeutics IncNBSE | 4 | Buy | $200.00 | N/A | Maintains | 3 years ago |
Barinthus Biotherapeutics PLCBRNS | 1 | Buy | $22.00 | N/A | Maintains | 3 years ago |
Sorrento Therapeutics IncSRNEQ | 4 | Buy | $20.00 | N/A | Maintains | 3 years ago |
Oramed Pharmaceuticals IncORMP | 2 | Buy | $32.00 | N/A | Maintains | 4 years ago |
Inmed Pharmaceuticals IncINM | 1 | Buy | $3,000.00 | N/A | Initiates Coverage On | 4 years ago |
Gri Bio IncGRI | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 4 years ago |
Synlogic IncSYBX | 3 | Buy | $105.00 | N/A | Maintains | 4 years ago |
Adamas Pharmaceuticals IncADMS | 2 | Hold | $9.10 | N/A | Downgrades | 4 years ago |
Redhill Biopharma LtdRDHL | 2 | Buy | $21,000.00 | N/A | Maintains | 4 years ago |
Itamar Medical LtdITMR | 3 | Hold | $31.00 | N/A | Downgrades | 4 years ago |
Immunic IncIMUX | 3 | Buy | $25.00 | N/A | Maintains | 4 years ago |
Acorda Therapeutics IncACORQ | 4 | Buy | $200.00 | N/A | Upgrades | 4 years ago |
Exicure IncXCUR | 2 | Buy | $900.00 | N/A | Maintains | 4 years ago |
Bausch Health Companies IncBHC | 4 | Buy | $55.00 | N/A | Maintains | 4 years ago |
Tff Pharmaceuticals IncTFFP | 2 | Buy | $925.00 | N/A | Maintains | 4 years ago |
Viela Bio IncVIE | 2 | Hold | $53.00 | N/A | Downgrades | 4 years ago |
Metavia IncMTVA | 2 | Buy | $3,840.00 | N/A | Maintains | 4 years ago |
Applied Dna Sciences IncAPDN | 5 | Buy | $210,000.00 | N/A | Maintains | 4 years ago |
Zosano Pharma CorpZSANQ | 2 | Buy | $2.50 | N/A | Maintains | 5 years ago |
Caredx IncCDNA | 3 | Buy | $40.00 | N/A | Maintains | 5 years ago |
Meridian Bioscience IncVIVO | 1 | Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Biospecifics Technologies CorpBSTC | 2 | Buy | $100.00 | N/A | Maintains | 5 years ago |
Cytodyn IncCYDY | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Replimune Group IncREPL | 1 | Hold | $25.00 | N/A | Downgrades | 5 years ago |
Igm Biosciences IncIGMS | 1 | Buy | $88.00 | N/A | Initiates Coverage On | 5 years ago |
Evoke Pharma IncEVOK | 2 | Buy | $1,440.00 | N/A | Upgrades | 5 years ago |
Springworks Therapeutics IncSWTX | 1 | Buy | $60.00 | N/A | Upgrades | 5 years ago |
Stemline Therapeutics IncSTML | 1 | Buy | $18.00 | N/A | Maintains | 5 years ago |
Kala Bio IncKALA | 3 | Buy | $600.00 | N/A | Reiterates | 6 years ago |
Entero Therapeutics IncENTO | 2 | Buy | $7.00 | N/A | Maintains | 6 years ago |
Celcuity IncCELC | 1 | Buy | $36.00 | N/A | Initiates Coverage On | 7 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $32.00 | N/A | Initiates Coverage On | 7 years ago |
Cormedix IncCRMD | 2 | Buy | $10.00 | N/A | Maintains | 7 years ago |
Ladrx CorpLADX | 1 | Buy | $4.50 | N/A | Maintains | 7 years ago |
Check Cap LtdCHEK | 1 | Buy | $280.00 | N/A | Maintains | 7 years ago |
Oncosec Medical IncONCSQ | 2 | Buy | $880.00 | N/A | Maintains | 7 years ago |
T2 Biosystems IncTTOO | 2 | Buy | $42,500.00 | N/A | Maintains | 7 years ago |
Lisata Therapeutics IncLSTA | 1 | Buy | $12.00 | N/A | Maintains | 7 years ago |
Durect CorpDRRX | 2 | Buy | $35.00 | N/A | Upgrades | 7 years ago |
Dentsply Sirona IncXRAY | 3 | Hold | $63.00 | N/A | Maintains | 7 years ago |
Aethlon Medical IncAEMD | 1 | Buy | $3,600.00 | N/A | Initiates Coverage On | 8 years ago |
Kiora Pharmaceuticals IncKPRX | 1 | Buy | $5.00 | N/A | Maintains | 8 years ago |
Bio Path Holdings IncBPTH | 1 | Buy | $6,000.00 | N/A | Maintains | 8 years ago |
Immuron LtdIMRN | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 8 years ago |
Foamix Pharmaceuticals LtdFOMX | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 8 years ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 8 years ago |
Alimera Sciences IncALIM | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.